National Institutes Of Health
T Trials shed light on benefits of testosterone therapy

Serum testosterone levels naturally begin to decline gradually with age, but not necessarily to levels below those considered normal for healthy young men. In the NIH-sponsored Testosterone Trials, researchers evaluated the effects of testosterone therapy in 790 men aged 65 years or older with low testosterone and symptoms possibly attributable to low testosterone. In the studies, which were conducted at 12 sites across the country, researchers randomly assigned participants to therapy with testosterone gel or placebo gel, applied daily to the skin. They then measured serum testosterone levels in the participants at 1, 2, 3, 6, 9 and 12 months.
Eltrombopag shows promise as first treatment for severe aplastic anemia
VIDEO: Anthony S. Fauci, MD, discusses significant advances in HIV/AIDS epidemic
VIDEO: Anthony Fauci, MD, discusses progress with malaria vaccine
Fauci expects less impact from Zika virus in Americas in 2017
SAN DIEGO – While there will be outbreaks of the Zika virus in the Americas this year, it is unlikely to be as severe as the outbreak that resulted in hundreds of thousands of cases in 2016, according to Anthony S. Fauci, MD, director of the NIH’s National Institute of Allergy and Infectious Diseases.
Anthony Fauci addresses past, present, future issue of emerging, reemerging infectious diseases at ACP

SAN DIEGO — While addressing the ACP membership during the Internal Medicine Meeting’s opening ceremony, Anthony S. Fauci, MD, MACP, director of the NIH’s National Institute of Allergy and Infectious Diseases, discussed the importance of treating and preventing emerging and reemerging infectious diseases.
NIH: Common screening tests ineffective at predicting preterm birth in first-time pregnancies
Among nulliparous women with singleton pregnancies, routine universal screening using quantitative vaginal fetal fibronectin and serial transvaginal ultrasound cervical length independently and combined had low predictive accuracy for subsequent spontaneous preterm birth and should not be used routinely in such women, according to research by the NIH published in JAMA.